AbstractGenital infection with Schistosoma haematobium is prevalent in sub-Saharan Africa. Epidemiological studies have observed that genital schistosomiasis is associated with an increased odd of HIV infection among women. We used mathematical modeling to explore the potential impact of mass preventive chemotherapy against schistosomiasis on HIV transmission in three sub-Saharan Africa countries: Angola, Kenya, and Zambia. We developed a model of female genital schistosomiasis (FGS) and HIV transmission dynamics, fitting it to data of HIV and S. haematobium prevalences as well as co-infection. We simulated targeted mass drug administration (MDA) with praziquantel to school-age children and mass treatment of the entire community. We estimat...
BACKGROUND: Schistosomiasis affects nearly 220 million people worldwide, mainly in Sub-Saharan Afric...
Over the past decade, a significant reduction in the prevalence of schistosomiasis has been achieved...
BACKGROUND: Over the past 20 years, schistosomiasis control has been scaled up. Preventive chemother...
AbstractGenital infection with Schistosoma haematobium is prevalent in sub-Saharan Africa. Epidemiol...
<div><p>Background</p><p>Epidemiological data from Zimbabwe suggests that genital infection with <i>...
Abstract. Women with female genital schistosomiasis (FGS) have been found to have genital symptoms a...
Human Immunodeficiency Virus-1/AIDS and Schistosoma mansoni are widespread in sub-Saharan Africa and...
Abstract. A prospective cohort study was conducted in two villages in Zambia to compare the efficacy...
Human Immunodeficiency Virus-1/AIDS and Schistosoma mansoni are widespread in sub-Saharan Africa and...
HIV/AIDS and schistosomiasis both cause a substantial disease burden in sub-Saharan Africa and the t...
Recent evidence suggests an association between human immunodeficiency virus (HIV) and female genita...
The last decade has seen an expansion of national schistosomiasis control programmes in Africa based...
Animal and human studies suggest that Schistosoma mansoni infection may increase risk of human immun...
OBJECTIVE: To evaluate the impact on schistosomiasis of biennial treatment with praziquantel (PZQ) a...
Abstract. Praziquantel is the drug of choice for schistosomiasis chemotherapy. Although the exact me...
BACKGROUND: Schistosomiasis affects nearly 220 million people worldwide, mainly in Sub-Saharan Afric...
Over the past decade, a significant reduction in the prevalence of schistosomiasis has been achieved...
BACKGROUND: Over the past 20 years, schistosomiasis control has been scaled up. Preventive chemother...
AbstractGenital infection with Schistosoma haematobium is prevalent in sub-Saharan Africa. Epidemiol...
<div><p>Background</p><p>Epidemiological data from Zimbabwe suggests that genital infection with <i>...
Abstract. Women with female genital schistosomiasis (FGS) have been found to have genital symptoms a...
Human Immunodeficiency Virus-1/AIDS and Schistosoma mansoni are widespread in sub-Saharan Africa and...
Abstract. A prospective cohort study was conducted in two villages in Zambia to compare the efficacy...
Human Immunodeficiency Virus-1/AIDS and Schistosoma mansoni are widespread in sub-Saharan Africa and...
HIV/AIDS and schistosomiasis both cause a substantial disease burden in sub-Saharan Africa and the t...
Recent evidence suggests an association between human immunodeficiency virus (HIV) and female genita...
The last decade has seen an expansion of national schistosomiasis control programmes in Africa based...
Animal and human studies suggest that Schistosoma mansoni infection may increase risk of human immun...
OBJECTIVE: To evaluate the impact on schistosomiasis of biennial treatment with praziquantel (PZQ) a...
Abstract. Praziquantel is the drug of choice for schistosomiasis chemotherapy. Although the exact me...
BACKGROUND: Schistosomiasis affects nearly 220 million people worldwide, mainly in Sub-Saharan Afric...
Over the past decade, a significant reduction in the prevalence of schistosomiasis has been achieved...
BACKGROUND: Over the past 20 years, schistosomiasis control has been scaled up. Preventive chemother...